Triforge 5:160:25 Tablet Price in Pakistan

View latest Price, manufacturer, formulation, and pack details of Triforge 5:160:25 Tablet.

Available Products of Triforge 5:160:25 Tablet

Triforge 5:160:25 Tablet 14

Reg#: 077001

Description of Triforge 5:160:25 Tablet

Amlodipine + valsartan + hydrochlorthiazide 5/160/25

Medicine Info

Pack Size: 14

Company: HIGHNOON LABORATORIES LIMITED

Price of Triforge 5:160:25 Tablet

Price: Rs. 245.59

Related Keywords

  • Triforge 5:160:25 Tablet price in Pakistan
  • Triforge 5:160:25 Tablet tablet price
  • Triforge 5:160:25 Tablet Capsule price
  • HIGHNOON LABORATORIES LIMITED Triforge 5:160:25 Tablet price
  • Buy Triforge 5:160:25 Tablet online
  • Triforge 5:160:25 Tablet uses
  • Triforge 5:160:25 Tablet syrup price
  • Triforge 5:160:25 Tablet pack 14 cost

Triforge 5:160:25 Tablet 28

Reg#: 077001

Description of Triforge 5:160:25 Tablet

Amlodipine + valsartan + hydrochlorthiazide 5/160/25

Medicine Info

Pack Size: 28

Company: HIGHNOON LABORATORIES LIMITED

Price of Triforge 5:160:25 Tablet

Price: Rs. 491.17

Related Keywords

  • Triforge 5:160:25 Tablet price in Pakistan
  • Triforge 5:160:25 Tablet tablet price
  • Triforge 5:160:25 Tablet Capsule price
  • HIGHNOON LABORATORIES LIMITED Triforge 5:160:25 Tablet price
  • Buy Triforge 5:160:25 Tablet online
  • Triforge 5:160:25 Tablet uses
  • Triforge 5:160:25 Tablet syrup price
  • Triforge 5:160:25 Tablet pack 28 cost

Alternatives brands of Triforge 5:160:25 Tablet

Explore alternative brands for Triforge 5:160:25 Tablet below.

View Alternatives

Explore More Medicines

Ulsanic suspension 1gm

HIGHNOON LABORATORIES LIMITED

MRP: Rs. 229.7757

Ulsanic Tablet 500 mg

HIGHNOON LABORATORIES LIMITED

MRP: Rs. 159.2705

Valforge Tablet 160 mg

HIGHNOON LABORATORIES LIMITED

MRP: Rs. 550.4312

Valforge Tablet 320 mg

HIGHNOON LABORATORIES LIMITED

MRP: Rs. 1834.7706

Valforge Tablet 40 mg

HIGHNOON LABORATORIES LIMITED

MRP: Rs. 197.1402

We’d love to hear your thoughts!

Share your comment below and join the conversation ✨

Comments

No comments yet. Be the first!